The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA Study
Open accessAbstract
Introduction: Work disability is a major consequence of rheumatoid arthritis (RA), associated not only with traditional disease activity variables, but also more significantly with demographic, functional, occupational, and societal variables. Recent reports suggest that the use of biologic agents offers potential for reduced work disability rates, but the conclusions are based on surrogate disease activity measures derived from studies primarily from Western countries. Methods: The Quantitative Standard Monitoring of Patients with RA (QUEST-RA) multinational database of 8,039 patients in 86 sites in 32 countries, 16 with high gross domestic product (GDP) (>24K US dollars (USD) per capita) and 16 low-GDP countries (<11K USD), was analyzed for work and disability status at onset and over the course of RA and clinical status of patients who continued working or had stopped working in high-GDP versus low-GDP countries according to all RA Core Data Set measures. Associations of work disability status with RA Core Data Set variables and indices were analyzed using descriptive statistics and regression analyses. Results: At the time of first symptoms, 86% of men (range 57%-100% among countries) and 64% (19%-87%) of women <65 years were working. More than one third (37%) of these patients reported subsequent work disability because of RA. Among 1,756 patients whose symptoms had begun during the 2000s, the probabilities of continuing to work were 80% (95% confidence interval (CI) 78%-82%) at 2 years and 68% (95% CI 65%-71%) at 5 years, with similar patterns in high-GDP and low-GDP countries. Patients who continued working versus stopped working had significantly better clinical status for all clinical status measures and patient self-report scores, with similar patterns in high-GDP and low-GDP countries. However, patients who had stopped working in high-GDP countries had better clinical status than patients who continued working in low-GDP countries. The most significant identifier of work disability in all subgroups was Health Assessment Questionnaire (HAQ) functional disability score. Conclusions: Work disability rates remain high among people with RA during this millennium. In low-GDP countries, people remain working with high levels of disability and disease activity. Cultural and economic differences between societies affect work disability as an outcome measure for RA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Need for a New Medical Model: A Challenge for Biomedicine
Engel, G. L. (1977) · Science · doi:10.1126/science.847460 · Cited by 12,887
Prevoo, M. L. L., Van'T Hof, M. A., Kuper, H. H., Van Leeuwen, M. A., Van De Putte, L. B. A., & Van Riel, P. L. C. M. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380107 · Cited by 6,243
Measurement of patient outcome in arthritis
Fries, J. F., Spitz, P., Kraines, R. G., & Holman, H. R. (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230202 · Cited by 4,382
Pincus, T., Callahan, L. F., Sale, W. G., Brooks, A. L., Payne, L. E., & Vaughn, W. K. (1984) · Arthritis & Rheumatism · doi:10.1002/art.1780270805 · Cited by 760
Self-citationPincus, T., Swearingen, C., & Wolfe, F. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199910)42:10<2220::aid-anr26>3.0.co;2-5 · Cited by 407
Self-citationWork Disability in Rheumatoid Arthritis: Effects of Disease, Social, and Work Factors
YELIN, E., MEENAN, R., NEVITT, M., & EPSTEIN, W. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-4-551 · Cited by 340
Puolakka, K., Kautiainen, H., Möttönen, T., Hannonen, P., Korpela, M., Hakala, M., Järvinen, P., Ahonen, J., Forsberg, S., & Leirisalo‐Repo, M. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20716 · Cited by 229
Self-citationSokka, T., Kautiainen, H., Toloza, S., Mäkinen, H., Verstappen, S. M. M., Lund Hetland, M., Naranjo, A., Baecklund, E., Herborn, G., Rau, R., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.069252 · Cited by 220
Self-citationSokka, T., Kautiainen, H., Pincus, T., Toloza, S., da Rocha Castelar Pinheiro, G., Lazovskis, J., Hetland, M. L., Peets, T., Immonen, K., Maillefert, J. F., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.109983 · Cited by 207
Self-citationWork disability in early rheumatoid arthritis.
Sokka, T. (2003) · PubMed · Cited by 180
Self-citationSokka, T., Krishnan, E., HÄKKINEN, A. H., & Hannonen, P. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10731 · Cited by 151
Self-citationCallahan, L. F., Bloch, D. A., & Pincus, T. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90005-8 · Cited by 151
Self-citationReisine, S., Grady, K. E., Goodenow, C. S., & Fifield, J. (1989) · Arthritis & Rheumatism · doi:10.1002/anr.1780320505 · Cited by 122
Markers for work disability in rheumatoid arthritis.
Sokka, T., & Pincus, T. (2001) · PubMed · Cited by 111
Self-citationØdegård, S., Finset, A., Kvien, T. K., Mowinckel, P., & Uhlig, T. (2005) · Scandinavian Journal of Rheumatology · doi:10.1080/03009740510018633 · Cited by 106
Association between etanercept use and employment outcomes among patients with rheumatoid arthritis
Yelin, E. H., Trupin, L. S., Katz, P., Lubeck, D. P., Rush, S., & Wanke, L. A. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11285 · Cited by 101
Verstappen, S. M. M., Boonen, A. E. R. C. H., Verkleij, H., Bijlsma, J. W. J., Buskens, E., & Jacobs, J. W. G. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.033977 · Cited by 81
Self-citationPrognosis of functional capacity and work capacity in rheumatoid arthritis
Mäkisara, G.-L., & Mäkisara, P. (1982) · Clinical Rheumatology · doi:10.1007/bf02275601 · Cited by 78
Wolfe, F., Allaire, S. H., & Michaud, K. D. (2007) · PubMed · Cited by 69
Augustsson, J., Neovius, M., Cullinane-Carli, C., Eksborg, S., & van Vollenhoven, R. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.108035 · Cited by 68
Treatment of rheumatoid arthritis: a global perspective on the use of antirheumatic drugs
Sokka, T., Envalds, M., & Pincus, T. (2008) · Modern Rheumatology · doi:10.1007/s10165-008-0056-x · Cited by 57
Self-citationAllaire, S. H., Wolfe, F., Niu, J., Zhang, Y., Zhang, B., & LaValley, M. P. (2008) · Arthritis Care & Research · doi:10.1002/art.23923 · Cited by 55
Chung, C. P., Sokka, T., Arbogast, P. G., & Pincus, T. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.048439 · Cited by 53
Self-citationPincus, T., Brooks, R. H., & Callahan, L. F. (1999) · PubMed · Cited by 47
Self-citation
Cited by
Smolen, J. S., Aletaha, D., & McInnes, I. B. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30173-8 · Cited by 4,870
Signaling pathways in rheumatoid arthritis: implications for targeted therapy
Ding, Q., Hu, W., Wang, R., Yang, Q., Zhu, M., Li, M., Cai, J., Rose, P., Mao, J., & Zhu, Y. Z. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01331-9 · Cited by 478
Hunter, T. M., Boytsov, N. N., Zhang, X., Schroeder, K., Michaud, K., & Araujo, A. B. (2017) · Rheumatology International · doi:10.1007/s00296-017-3726-1 · Cited by 450
Rahmati, M., Mobasheri, A., & Mozafari, M. (2016) · Bone · doi:10.1016/j.bone.2016.01.019 · Cited by 374
The need to address the burden of musculoskeletal conditions
Woolf, A. D., Erwin, J., & March, L. (2012) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2012.03.005 · Cited by 357
Self-citation
Metadata
- Authors
- Sokka, T., Kautiainen, H., Pincus, T., Verstappen, S. M., Aggarwal, A., Alten, R., Andersone, D., Badsha, H., Baecklund, E., Belmonte, M., Craig-Müller, J., da Mota, L. M. H., Dimic, A., Fathi, N. A., Ferraccioli, G., Fukuda, W., Géher, P., Gogus, F., Hajjaj-Hassouni, N., Hamoud, H., Haugeberg, G., Henrohn, D., Horslev-Petersen, K., Ionescu, R., Karateew, D., Kuuse, R., Laurindo, I. M. M., Lazovskis, J., Luukkainen, R., Mofti, A., Murphy, E., Nakajima, A., Oyoo, O., Pandya, S. C., Pohl, C., Predeteanu, D., Rexhepi, M., Rexhepi, S., Sharma, B., Shono, E., Sibilia, J., Sierakowski, S., Skopouli, F. N., Stropuviene, S., Toloza, S., Valter, I., Woolf, A., Yamanaka, H., & the QUEST-RA study group
- Venue
- Arthritis Research & Therapy
- Published
- 2010-03-12
- Volume
- 12
- Issue
- 2
- Pages
- R42-R42
- ISSN
- 1478-6354 (ISSN-L)
- OpenAlex
- W2162260707
- Cited by
- 284
- References
- 24
- FWCI
- 13.45
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.